Pharmhouse Corp Cash Flow Reinvestment Rate

Latest as of June 2026: 0.00x

Pharmhouse Corp cash flow reinvestment rate. Pharmhouse Corp (PHSE) has a Cash Flow Reinvestment Rate of 0.00x as of June 2026, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $362.87K. Explore Pharmhouse Corp cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$0.00
Capex + Investments

Operating Cash Flow

$362.87K
USD

Capital Expenditures

$0.00
USD

Cash Flow Reinvestment Rate of Pharmhouse Corp (2019–2023)

Cash flow reinvestment rate of Pharmhouse Corp from 2019 to 2023. Historical reinvestment intensity for Pharmhouse Corp across 2 annual periods. Explore Pharmhouse Corp (PHSE) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Pharmhouse Corp Cash Flow Reinvestment Rate by Year (2019–2023)

Pharmhouse Corp cash flow reinvestment rate by year from 2019 to 2023. Year-by-year capital reinvestment analysis for Pharmhouse Corp. For the full cash flow conversion analysis, see how efficiently does Pharmhouse Corp generate cash.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2023 0.00x $0.00 $1.71 Million $0.00 —
2019 0.00x $0.00 $652.00 $0.00 —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow